Mosquirix, a new vaccine
from GSK for malaria, along with
10 other new medicines, has
been approved by the European
Medicines Agency in the July
meeting of the Committee for
Medicinal Products for Human Use.
Other approvals included Praluent
(alirocumab) for cholesterol
lowering, Cresemba (isavuconazole)
for aspergillosis and mucormycosis,
Zerbaxa (ceftolozane/tazobactam)
for post-operative pain, Ivabradine
Anpharm (ivabradine) plus
two generic meds and some
recommendations for extensions of
indication.The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jul 15
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
THE University of South Australia has released a new study to help healthcare workers better support women with persistent pelvic pain, including symptoms that are suggestive of gynaecological, lower urinary tract, bowel, sexual, and pelvic floor dysfunction.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.